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Demographic and lifestyle information from 9690 black patients diagnosed with cancer or cardiovascular disease was collected in an
ongoing case–control study in Johannesburg, South Africa. Compared to never smokers, the odds ratio (OR) for lung cancer among
current smokers was 16.3 (95% confidence interval (CI), 9.6–27.6) for men and 6.4 (95% CI, 4.0–10.4) for women. The
corresponding OR for other smoking-related cancers was 4.6 (95% CI, 3.7–5.7) among men and 1.9 (95% CI, 1.6–2.2) among
women, and for cardiovascular disease, 3.4 (95% CI, 2.1–5.4) among men and 1.5 (95% CI, 1.1–2.1) among women. Risks were
higher among smokers than former smokers, and all risk estimates increased with increasing levels of smoking duration and intensity.
Non-electric domestic fuel was associated with approximately 60% increase in the risk of smoking-related cancer, but not
cardiovascular disease. Risks for cancers of cervix, oesophagus, oral cavity/pharynx, stomach, larynx, pancreas and anogenital region, as
well as squamous cell carcinoma of skin were all significantly higher among current than never-smokers, with ORs ranging from 1.5 for
cervix (95% CI, 1.2–1.8) to 14.7 for larynx (95% CI, 7.2–30). The risks of tobacco-related disease reported here are similar to that
currently observed in Western countries, even though cigarette consumption is relatively low in this population.
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Certain findings from an ongoing case–control study, which began
in 1995, of lifestyle and infectious risk factors for cancer among the
black African community of wider Johannesburg, South Africa
have been reported (Sitas et al, 1999, 2000, 2007; Pacella-Norman
et al, 2002; Wojcicki et al, 2003, 2004; Berrington et al, 2006).
These include elevated risks associated with tobacco smoking and
cancers of the oesophagus, lung, oral cavity and larynx (Pacella-
Norman et al, 2002) that were broadly consistent with interna-
tional findings (Vineis et al, 2004). The sample size has doubled
since the 2002 report, allowing estimates of smoking-related risks
of less common cancers (Vineis et al, 2004).
The study began just after the implementation of South Africa’s
first tobacco control legislation and since then both smoking
prevalence and overall tobacco consumption has decreased
dramatically. In 1995, smoking prevalence among adults was
30.2% and by 2004 it fell to 24.1% (Saloojee, 2006), while in the 10
years to 2001 cigarette consumption had decreased by one-third
(Saloojee, 2006). The black African community of South Africa,
which accounts for almost two-thirds of the population, has the
lowest levels of smoking prevalence within the country (22.7% in
2000, down from 28.1% in 1993) (van Walbeek, 2002a) and
consumes the least amount of cigarettes (averaging 7 per day in
1998) (Steyn et al, 2002). This partly reflects cultural beliefs and
partly poverty on which the excise tax on tobacco has had the
greatest effect (van Walbeek, 2002b). The smoking-related cancers
of oesophagus, lung, larynx, stomach and cervix remain leading
cancer types among black South Africans (Norman et al, 2006).
The aim of this analysis was to provide local estimates of the
risks associated with smoking for smoking-related cancers and
cardiovascular disease, and to explore the effects of duration,
intensity and cessation of smoking on these estimates. Because
tobacco smoking is associated with several squamous cell cancers
(e.g., oral cavity, oesophagus, cervix), we also investigated the
squamous cell cancer of the skin (SCC skin), as well as anogenital
sites (other than cervix), in relation to smoking.
MATERIALS AND METHODS
The Johannesburg Cancer Case Control Study is based in the three
main public referral hospitals of Johannesburg and Soweto.
General methods have been described elsewhere (Sitas et al,
1999). In addition, in 1998–2001, patients presenting with
cardiovascular diseases were included. The study was approved
by the University of the Witwatersrand Human Research Ethics
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patients 18 years old or older who had a newly diagnosed cancer or
a cardiovascular disease and who were interviewed between March
1995 and June 2004.
In our first series of analyses, the data were arranged into four
groups, a control group and three different ‘disease’ case groups.
The control group comprised data from 4059 patients who had
cancer thought not to be associated with tobacco smoking, and the
three case groups comprised patients with (1) lung cancer (423),
(2) other cancers known to be associated with tobacco smoking –
‘smoking-related’ (3961), or (3) a cardiovascular disease (716)
(Table 1). In a second series of analyses, risks associated with
smoking were calculated separately for cancers included in the
‘smoking-related’ group (where n410), as well as anogenital
cancers and SCC skin (Table 1).
Altogether, 287 cancer cases were excluded from all analyses
because either the cancer was at a secondary site (C77) or the
number of cases was small, that is, cancers of the heart (C38),
gall bladder (C23), skin (C44 – not SCC), mesothelioma (C45),
unspecified genital cancers (C57, C58) and unspecified cancers of
the digestive system (C24, C26).
The first series of analyses were stratified by gender and patients
were grouped according to particular risk factors, that is, age (18–
34, 35–54, 55–98), education (0–5, 6–9, 9þ years), type of
domestic cooking fuel (electrical or non-electrical – i.e., wood,
charcoal, coal, anthracite, paraffin, or gas), and tobacco smoking
status (never, former, current). Since some patients may have
given up smoking due to their illness, those who smoked within 5
years of the interview date were classified as current smokers,
while those who stopped smoking before this time were classified as
former smokers. Never smokers were participants who answered
‘Never’ to the question, ‘Have you ever smoked cigarettes or a pipe
regularly?’ Patients were also grouped according to how much
tobacco they smoked per day (0, 1–14, 15gþ assuming weights of
1g for commercial cigarettes, 1g for hand-rolled cigarettes, and a
conservative 1g per pipeful), the number of years they smoked (0,
1–20, 21þ) and how many ‘pack-years’ they smoked (i.e., number
of packs smoked per day multiplied by the number of years smoked;
0, 1–10, 11–20, 21–30, 31þ). A ‘pack’ was assumed to contain 20
cigarettes (or 20 hand-rolled cigarettes or 20 pipefuls). As the
number of former smokers who smoked more than 30 pack-years
was insufficient for analysis, the highest level of pack-years
calculated for former smokers was 21 or more.
In the second series of analyses, the data were grouped
according to cancer site and distributed by smoking status (never,
former, current), but were not stratified by gender due to small
numbers of most cancers.
Statistical analyses
Relative risks for the association of each risk factor and cancer/
cardiovascular disease were estimated by using the odds ratios
(ORs) derived from unconditional, unmatched multiple logistic
regression. A separate term was used for each adjustment factor in
the model, and these included: age, education level, and type of
domestic cooking fuel. The risk estimates for each individual
cancer site in the second series of analyses were also adjusted for
gender and alcohol intake (ever/never). A w
2 test for trend/
heterogeneity, adjusting for all other stratification levels, was used
to test for significance across exposure levels. Missing variables
were added to all regression models as a separate term and are
presented in tables as ‘unspecified’.
RESULTS
The study population was primarily female (65%) with a median
age of 52. The median education level was 7 years of schooling
(primary school). Many (30%) participants reported current use of
non-electric domestic cooking fuel and 41% stated that they had
ever smoked, of whom just over one-third had quit 5 or more years
prior to interview. Thus, for the purposes of our analyses, 26.6% of
the study population were classified as current smokers (13% of
Table 1 Diseases grouped for analysis
Site ICD-10 n
Smoking-unrelated cancers
Breast C50 1442
Prostate C61 402
Kaposi’s sarcoma C46 384
Colon C18-C20 333
Non-Hodgkin’s lymphoma C82, C83 239
Endometrium C54, C55 199
Myeloma C90 197
Ovaries C56 196
Hodgkin’s disease C81 156
Leukaemia (not myeloid) C91-C95 116
Soft tissue sarcoma C49 105
Bone C40, C41 71
Melanoma C43 58
Thyroid C73 44
Brain C71 30
Endocrine gland C75 27
Eye and adnexa C69 13
Meninges C70 13
Testes C62 9
Peritoneum and retroperitoneum C48 7
Peripheral nerves and ANS C47 5
CNS C72 5
Thymus C37 4
Small intestine C17 3
Unspecified lymphoid C96 1
Lung cancer C33, C34 423
Squamous cell carcinoma (SCC)
of the skin
C44 (M8070–8076, M8560,
M8081, M8051-2)
70
Smoking-related cancers
Cervix C53 1885
Oesophagus C15 901
Oral cavity and pharynx C00–C10, C12–C14 369
Myeloid leukaemia C92 213
Stomach C16 162
Larynx C32 139
Liver C22 88
Nasal cavity and nasopharynx C11, C30, C31 71
Pancreas C25 53
Bladder C67 47
Kidney C64 25
Unspecified urinary C68 7
Ureter C66 1
Anogenital cancers
Vulva C51 107
Anus C20 31
Penis C60 22
Vagina C52 14
Cardiovascular diseases
Hypertention I10–I15 266
Stroke I64 176
Congestive heart failure I50 141
Pulmonary heart disease I26, I27 40
Cerebral infarction I63 37
Cardiovascular disease I51 29
Ischaemic heart disease I24, I25 10
Other vascular diseases I05–I09, I20, I21, I31, I34,
I40, I42, I61, I67, I80 17
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women and 24% of all men), and 59.4% as never smokers (78% of
women and 23% of men).
Subjects are tabulated by age, education, smoking status and
type of domestic cooking fuel in Table 2. Patients with lung cancer
were primarily male (79%), over the age of 54 (60%), ‘ever’
smokers (85%), completed a maximum of only 5 years of schooling
(68%), and used electricity for cooking (69%). Patients with a
smoking-related cancer (other than lung) were primarily male
(66%) with ages spread evenly across the 34–54 (46%) and 54–98
age groups (47%), ‘never’ smokers (54%), were schooled for a
maximum of 5 years (64%), and 64% used electricity for cooking.
Patients with cardiovascular disease were mainly female (78%),
with ages spread evenly across the 34–54 (44%) and 54–98 (42%)
age groups, with 61% never smokers, 49% with a maximum of
5 years education, and 75% used electricity for cooking.
For both sexes, lung cancer was significantly associated with age
and smoking status (Table 2). There was a significant trend in lung
cancer risk increasing with age, and with former smokers having a
two-fold lower risk than current smokers. Education and type of
domestic cooking fuel were associated with lung cancer among
men only. Specifically, increased levels of education were
associated with a significantly lower risk of lung cancer among
men, and lung cancer risk was higher among men who used non-
electric cooking fuel.
Smoking-related cancer was significantly associated with age,
education, smoking status and type of cooking fuel for both sexes
(Table 2). Significant trends in the risk of smoking-related cancer
included lower risks among those with higher levels of education,
lower risks among former than current smokers, and higher risks
among those without electric cooking facilities. Among men, there
was a significant trend in the risk of smoking-related cancer
increasing with age, but this was not significant among women.
Cardiovascular disease was associated with smoking status for
both sexes, with significant lower risk estimates among former
smokers than current smokers. Education and domestic cooking
fuel were not associated with cardiovascular disease. Age was
associated with cardiovascular disease only among men, with
participants in the 35–54 years age group at a higher risk than
those in the 18–34 years age group.
The use of non-electric domestic cooking fuel was significantly
associated with lung cancer (men only) and other smoking-related
cancers, but not cardiovascular disease. However, the risk of
disease associated with smoking and cooking fuel increased when
these two factors were combined. Specifically, ‘ever’ smokers of
both sexes increased their risk of a smoking-related cancer or lung
cancer by approximately 60% if they also used non-electric
cooking fuel; ever smokers among men increased their risk of a
cardiovascular disease by 30%. However, among women, this fuel
did not increase cardiovascular disease risk above that of ever
smokers (Table 2).
The distribution of cases and controls according to number of
years smoked, amount of tobacco smoked per day and number of
pack-years is shown in Table 3, and each of these variables were
significantly associated with all three case groups. There were
significant trends across exposure levels for all groups, where risk
estimates increased with greater numbers of years smoked, greater
amounts of tobacco smoked per day, and with increasing pack-
years. Men had higher risks in all the three disease groups than
women in terms of all smoking variables analysed. Risks for
current smokers across all exposure levels were consistently higher
than for former smokers.
The association between smoking and site-specific cancers is
presented in Figure 1. Cancers of cervix, stomach, pancreas,
oesophagus, anogenital region (excluding cervix), oral cavity/
pharynx, lung, larynx, and SCC skin were all significantly
associated with current smoking (Figure 1A). Sites among current
smokers that showed nonsignificant elevated risks included the
bladder, liver, kidney, and nasal cavity/nasopharynx cancers. In
former smokers (Figure 1B), the relative risks were 1.3–3.3 times
lower than for current smokers, except for myeloid leukaemia
where the risk was significantly higher for former smokers.
Relative risk estimates for former smokers remained significantly
above those of never smokers for cancers of the stomach,
anogenital region, oesophagus, oral cavity/pharynx, lung and
larynx, and for myeloid leukaemia.
DISCUSSION
Using a hospital-based sample of black African patients in
Johannesburg, South Africa, this study found elevated risks
associated with smoking and cancers of the lung, other smoking-
related cancers (i.e., cancers of the cervix, oesophagus, oral cavity
and pharynx, stomach, larynx, liver, nasal cavity and nasopharynx,
pancreas, bladder, kidney and other urinary sites, and myeloid
leukaemia, pooled), and cardiovascular disease, which are similar
to international findings (Vineis et al, 2004). All smoking-related
risk estimates increased with both the number of years smoked
and the amounts smoked daily. All risk estimates were signifi-
cantly lower among former smokers, and were higher overall for
men. The use of non-electric domestic cooking fuel was associated
with increased risks of lung and other smoking-related cancers,
but not of cardiovascular disease. When combined with smoking,
the risk of cardiovascular disease was also significantly associated
with its use in men, but not in women, and the risk of lung and
other smoking-related cancers was further increased for both
sexes.
In 2002, the first report on tobacco-related cancer risk from this
study was published, comprising just over 4200 participants who
were interviewed between 1995 and 1999 (Pacella-Norman et al,
2002). With our larger sample size, the risks associated with
tobacco smoking reported here are slightly different. Specifically,
the relative risk of lung cancer among smokers is now estimated to
be higher for men and lower for women when compared to the
original report. However, with the increase in the number of lung
cancer cases (increased from 110 to 333 in men and 41 to 90 in
women), the risk estimates are now more precise.
The 2002 report also investigated an association between
non-electric domestic fuel and cancer. With a very small sample
size (n¼6/7), it was found that use of paraffin ‘20 years ago’ for
heating was associated with lung cancer in men and oesophageal
cancer in women. In the current analysis, we pooled the use of
non-electric fuels (including paraffin) and found that a ‘current’
use of non-electric fuel for cooking was associated with a 60%
increase in the odds of a smoking-related cancer for both sexes.
Non-electric cooking fuel also increased the risk of lung cancer
alone by about 60% among men but not in women. Of those
reporting a current use of non-electric cooking fuel, 37% used coal,
24% used wood, and 34% used paraffin. The rest were users of gas
(4.9%), charcoal (0.2%), or anthracite (0.03%). Residential stoves
that use biomass fuels or coal produce extremely high levels of
indoor air pollution in the form of particulate matter, nitrogen
dioxide, carbon monoxide, and in particular, of carcinogenic
polynuclear aromatic compounds such as benzo(a)pyrene, ben-
zene and 1,3-butadiene (IARC, 1985; Cohen et al, 2004). Particulate
air pollution has been estimated to account for 5% of lung cancer
deaths worldwide (Cohen et al, 2004), so a significant association
of domestic cooking fuel and smoking-related cancers in this study
is not surprising.
The larger size of the current study allowed for examination of
smoking duration, intensity and cessation. Most men with lung
cancer were current smokers who had smoked for over 20 years,
and their risk of lung cancer was four-fold higher than smokers of
shorter durations. In contrast, most women with lung cancer
reported being ‘never smokers’. Nevertheless, current female
Cancer and cardiovascular disease associated with smoking
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a
Controls
b Lung Cancer Smoking-related cancer
b Cardiovascular disease
c
Male Female
Male Female Male Female Male Female
n¼1383 n¼2676
n¼333 95% CI n¼90 95% CI n¼1330 95% CI n¼2631 95% CI n¼159 95% CI n¼557 95% CI
Risk factor nn n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI
Age
18–34 253 412 5 1.0 Referent 2 1.0 Referent 90 1.0 Referent 213 1.0 Referent 22 1.0 Referent 77 1.0 Referent
35–54 478 1212 136 12.5 5.0 31.4 27 2.8 0.6 12.1 530 2.4 1.8 3.3 1283 1.5 1.2 1.8 88 2.0 1.2 3.4 228 0.8 0.6 1.1
55–98 650 1050 192 15.4 6.1 38.7 61 7.1 1.7 30.3 710 2.5 1.9 3.4 1134 1.4 1.1 1.7 49 0.8 0.4 1.5 252 1.0 0.7 1.4
w
2 (P trend) 35.0 (o0.0001) 19.2 (o0.0001) 23.2 (o0.0001) 2.7 (0.10) 2.1 (0.15) 0.5 (0.50)
Unspecified 2 2 0 — — — 0 — — — 0 — — — 1 — — — 0 — — — 0 — — —
Education (years)
0–5 761 1317 226 1.0 Referent 61 1.0 Referent 848 1.0 Referent 1683 1.0 Referent 66 1.0 Referent 287 1.0 Referent
6–8 371 888 87 0.9 0.7 1.2 27 1.1 0.7 1.8 352 0.9 0.8 1.1 728 0.8 0.7 0.9 45 1.2 0.8 1.9 201 1.1 0.9 1.4
9+ 243 462 19 0.5 0.3 0.8 2 0.3 0.1 1.2 121 0.7 0.5 0.9 189 0.5 0.4 0.6 27 1.2 0.7 2.1 67 0.7 0.5 1.0
w
2 (P trend) 5.4 (0.02) 1.3 (0.26) 4.6 (0.03) 59.8 (o0.0001) 0.7 (0.41) 1.4 (0.24)
Unspecified 8 9 1 0.8 0.1 8.0 0 — — — 9 1.6 0.6 4.8 31 3.1 1.5 6.6 21 6.1 1.0 36.4 2 1.1 0.2 5.1
Smoking status
d
Never 528 2264 16 1.0 Referent 46 1.0 Referent 176 1.0 Referent 1970 1.0 Referent 25 1.0 Referent 412 1.0 Referent
Former 338 167 83 7.2 4.1 12.6 12 2.6 1.3 5.1 344 2.8 2.2 3.5 235 1.4 1.1 1.8 23 1.6 0.9 2.8 82 2.6 1.9 3.4
Current 513 227 234 16.3 9.6 27.6 32 6.4 4.0 10.4 808 4.6 3.7 5.7 407 1.9 1.6 2.2 90 3.4 2.1 5.4 63 1.5 1.1 2.1
w
2 (P trend) 142.4 (o0.0001) 58.2 (o0.0001) 189.0 (o0.0001) 50.5 (o0.0001) 29.3 (o0.0001) 15.0 (o0.0001)
Ever 851 394 317 12.2 7.3 20.6 44 4.6 3.0 7.2 1152 3.9 3.2 4.7 642 1.7 1.4 1.9 113 2.7 1.7 4.3 145 2.0 1.6 2.5
Unspecified 4 18 — — — 0 — — — 2 2.0 0.3 13.0 19 1.1 0.6 2.2 15.3 2.1 111.7 0 — — —
Cooking fuel
e
Electrical 1079 1970 230 1.0 Referent 60 1.0 Referent 937 1.0 Referent 1588 1.0 Referent 104 1.0 Referent 432 1.0 Referent
Non-electrical 300 703 103 1.6 1.2 2.2 30 1.4 0.8 2.2 390 1.5 1.3 1.9 1030 1.6 1.4 1.8 34 1.2 0.8 1.8 125 0.8 0.6 1.0
w
2 (P heterogeneity) 10.1 (0.002) 1.6 (0.20) 19.4 (o0.0001) 59.6 (o0.0001) 0.5 (0.47) 3.7 (0.05)
Unspecified 4 3 0 — — — 0 — — — 3 0.6 0.1 3.4 13 5.1 1.4 18.3 21 5.1 0.7 37.2 0 — — —
Smoking status by cooking fuel
Never smoke/electrical 397 1662 11 1.0 Referent 31 1.0 Referent 113 1.0 Referent 1178 1.0 Referent 17 1.0 Referent 326 1.0 Referent
Never smoke/non-electrical 131 600 5 1.4 0.5 4.0 15 1.3 0.7 2.4 63 1.6 1.1 2.4 782 1.6 1.4 1.8 8 1.5 0.6 3.6 86 0.7 0.5 0.9
Ever smoke/electrical 681 293 219 11.1 6.0 20.8 29 4.3 2.5 7.3 824 3.9 3.1 5.0 399 1.7 1.4 2.0 87 3.0 1.8 5.2 106 1.8 1.4 2.3
Ever smoke/non-electrical 167 101 98 20.1 10.4 38.9 15 6.8 3.5 13.4 326 6.1 4.6 8.2 241 2.7 2.1 3.5 26 3.6 1.8 7.0 39 1.9 1.3 2.9
w
2 (P trend) 117.8 (o0.0001) 44.6 (o0.0001) 188.0 (o0.0001) 91.6 (o0.0001) 18.1 (o0.0001) 17.9 (o0.0001)
Unspecified 7 20 0 — — — 0 — — — 4 2.0 0.5 7.5 31 2.0 1.1 3.6 21 15.8 4.0 62.1 0 — — —
aAnalyses adjusted for age, education, smoking status, and cooking fuel; odds ratios (OR) with 95% lower (LCI) and upper (UCI) confidence intervals presented.
bSee Table 1 for disease groupings.
cPrimarily hypertenstion (37%),
stroke (25%) and congestive heart failure (18%).
dCurrent smokers included those who smoked within 5 years of interview.
eNon-electrical cooking fuel included wood, charcoal, coal, anthracite, parafin, and gas.
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EpidemiologyTable 3 Risk of lung cancer, other smoking-related cancers, and cardiovascular disease distributed by smoking variables
a
Controls
b Lung cancer Smoking-related cancer
b Cardiovascular disease
c
Male Female
Male Female Male
Female
n¼159 95% CI
n¼1383 n¼2676
n¼333 95% CI n¼90 95% CI n¼1330 95% CI n¼2631 95% CI n¼159 95% CI n¼557 95% CI
Risk factor nn n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI n OR LCI UCI
Years smoked
Never smoked 528 2264 16 1.0 Referent 46 1.0 Referent 176 1.0 Referent 1970 1.0 Referent 25 1.0 Referent 412 1.0 Referent
Former smoker
1–20 69 62 15 6.0 3.5 10.4 1 2.6 0.9 7.6 56 2.3 1.6 3.5 58 0.9 0.7 1.4 14 4.3 2.1 8.9 12 1.0 0.6 2.0
21+ 53 32 22 10.1 6.0 17.1 29 2.0 0.4 8.5 53 2.8 1.8 4.3 46 1.5 1.0 2.4 7 4.9 1.9 12.5 10 1.5 0.7 3.1
w
2 (P trend) 49.1 (o0.0001) 2.2 (0.13) 38.2 (o0.0001) 1.1 (0.29) 15.0 (o0.0001) 1.3 (0.26)
Current smoker
1–20 189 59 15 5.1 2.8 9.3 4 1.4 0.2 10.5 98 1.8 1.3 2.5 60 1.2 0.8 1.8 19 1.5 0.7 2.8 14 1.3 0.7 2.4
21+ 298 155 210 20.1 14.9 27.2 2 7.4 4.5 12.3 661 6.1 4.9 7.7 319 2.1 1.7 2.5 70 5.5 3.2 9.2 47 1.7 1.2 2.3
w
2 (P trend) 131.2 (o0.0001) 59.2 (o0.0001) 240.8 (o0.0001) 45.4 (o0.0001) 36.8 (o0.0001) 8.4 (0.004)
Unspecified 246 104 55 7.1 4.9 10.4 8 3.1 1.4 6.8 286 3.4 2.6 4.3 178 1.7 1.3 2.2 24 0.5 0.2 1.3 62 3.2 2.3 4.4
Tobacco/day
d
Never Smoked 528 2264 16 1.0 Referent 46 1.0 Referent 176 1.0 Referent 1970 1.0 Referent 25 1.0 Referent 412 1.0 Referent
Former smoker
1–14g 243 137 45 5.4 3.0 9.8 11 2.9 1.5 5.8 197 2.3 1.7 2.9 203 1.5 1.2 1.9 15 1.5 0.7 2.9 63 2.4 1.7 3.3
15+g 88 19 36 11.7 6.2 22.2 1 2.0 0.3 15.4 138 4.1 3.0 5.7 25 1.3 0.7 2.3 8 2.1 0.9 4.8 17 4.8 2.5 9.4
w
2 (P trend) 63.1 (o0.0001) 7.7 (0.006) 100.0 (o0.0001) 10.6 (0.001) 3.9 (0.05) 45.5 (o0.0001)
Current smoker
1–14g 405 202 113 10.4 6.0 18.0 23 5.3 3.1 9.0 554 4.1 3.3 5.1 353 1.8 1.5 2.2 61 2.9 1.8 4.7 49 1.3 1.0 1.9
15+g 95 20 115 37.4 21.0 66.5 9 18.5 7.7 44.5 241 6.8 5.1 9.2 50 2.6 1.5 4.5 29 6.1 3.4 11.1 14 3.9 1.9 7.8
w
2 (P trend) 183.5 (o0.0001) 67.2 (o0.0001) 196.3 (o0.0001) 48.4 (o0.0001) 36.3 (o0.0001) 13.1 (0.001)
Unspecified 24 34 8 10.2 3.9 26.7 0 — — — 24 2.8 1.5 5.2 30 0.9 0.5 1.4 21 1.7 0.4 7.0 2 0.3 0.1 1.4
Pack years
e
Never Smoked 528 2264 16 1.0 Referent 46 1.0 Referent 176 1.0 Referent 1970 1.0 Referent 25 1.0 Referent 412 1.0 Referent
Former smoker
1–10 75 76 18 7.2 3.5 14.8 5 2.5 1.0 6.5 63 2.3 1.6 3.4 76 1.0 0.8 1.5 13 3.5 1.7 7.3 19 1.3 0.8 2.2
11–20 27 9 8 8.4 3.3 21.6 1 3.5 0.4 28.8 19 1.8 1.0 3.4 14 1.6 0.7 3.6 4 4.3 1.3 13.7 2 1.1 0.2 5.2
21+ 20 6 11 15.8 6.4 38.7 0 — — — 25 3.4 1.8 6.3 13 2.0 0.8 5.4 4 7.0 2.1 23.4 1 0.9 0.1 7.3
w
2 (P trend) 46.6 (o0.0001) 2.3 (0.13) 34.7 (o0.0001) 2.5 (0.11) 16.6 (o0.0001) 0.4 (0.52)
Current smoker
1–10 257 140 48 8.1 4.4 14.7 9 3.4 1.6 7.1 257 3.3 2.6 4.2 198 1.5 1.2 1.9 44 3.0 1.7 5.1 35 1.4 0.9 2.1
11–20 117 51 46 11.6 6.3 21.4 9 7.0 3.2 15.3 215 4.9 3.7 6.6 107 2.1 1.5 3.0 15 2.3 1.2 4.7 10 1.1 0.5 2.1
21–30 64 9 42 18.8 9.9 35.7 7 30.0 10.3 87.6 126 5.3 3.7 7.5 44 5.1 2.5 10.5 6 2.1 0.8 5.3 7 4.0 1.5 10.7
31+ 41 12 85 54.9 29.3 102.9 5 13.0 4.3 39.3 152 9.5 6.4 14.0 26 2.2 1.1 4.4 24 17.8 8.8 35.9 9 4.0 1.7 9.7
w
2 (P trend) 190.0 (o0.0001) 64.8 (o0.0001) 188.4 (o0.0001) 44.3 (o0.0001) 43.6 (o0.0001) 14.4 (o0.0001)
Unspecified 254 109 59 7.0 3.9 12.5 8 3.0 1.3 6.5 297 3.3 2.6 4.2 183 1.7 1.3 2.2 24 0.5 0.2 1.2 62 3.0 2.2 4.2
aAnalyses adjusted for age, education, smoking status, and cooking fuel; odds ratios (OR) with 95% lower (LCI) and upper (UCI) confidence intervals presented.
bSee Table 1 for disease groupings.
cPrimarily hypertenstion (37%),
stroke (25%) and congestive heart failure (18%).
dIncluded cigarettes, hand-rolled cigarettes, and pipes.
ePack Years calculated by dividing the number of grams of tobacco smoked per day by 20 (1 packet) and then multiplying by the
number of years smoked.
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ysmokers of more than 20 years had five times the risk of former
smokers. There was a 3.5-fold increase in the risk of lung cancer
between both men and women who smoked more than 15g
tobacco per day compared to those who smoked less. Furthermore,
heavy smoking over a long period yielded a risk of lung cancer that
was almost 55 times higher than that of never-smokers in men and
13 times higher in women. However, quitting for at least a 5-year
period resulted in a two-fold lower risk of lung cancer overall. A
similar pattern of results was found for the risks of smoking-
related cancers and cardiovascular disease, where there was a
positive dose–response trend for both smoking duration and
intensity and an inverse relationship with smoking cessation.
The larger sample size allowed for examination of rarer cancer
types. After adjusting for age, gender, education, alcohol intake,
and domestic cooking fuel, among current smokers the risk of
cancers of the lung, larynx, oesophagus, stomach, pancreas,
cervix, anogenital region, oral cavity/pharynx, and SCC skin were
higher than among never smokers. The risk of all these cancers
was lower among former smokers, however, remained significantly
above that of never smokers for cancers of the larynx, lung,
oesophagus, oral cavity/pharynx, anogenital region, and stomach.
This trend was not apparent for myeloid leukaemia, where the
association with smoking was significantly elevated among
former smokers but not current smokers; as this is smoking
related, it is probably a chance result that may disappear as more
cases accrue (The International Agency for Research on Cancer
(IARC, 2002).
Almost all of the cancers examined in this analysis were chosen,
because they were identified as being partly caused by tobacco
smoke in reports from the IARC working group (IARC, 2002; Vineis
et al, 2004). However, in our study, the relative risk for cancers of
the liver, kidney, bladder, and nasal cavity/nasopharynx were
elevated but not significantly associated, perhaps because of the (1)
small sample sizes; (2) shared exposures between cases and controls
other than those used for adjustment (e.g., virus infection, diet,
occupation, place of residence); or (3) within this particular
population, smoking is not a risk factor for these cancer sites.
Evidence for a relationship of SCC of the skin and cancers of
anogenital organs (other than cervix) with smoking remains
sparse. A few studies have found smokers to be at a higher risk of
cancers of the anus (Daling et al, 1992; Northfelt, 1996; Frisch et al,
1999; Tseng et al, 2003), vulva (Daling et al, 1992; Zarcone et al,
1997), and penis (Daling et al, 1992; Maden et al, 1993), but not of
the vagina (Daling et al, 1992). In our study, current smokers were
4.3 (95% confidence interval (CI), 2.9–6.4) times more likely than
never smokers to have one of these cancers (including vaginal
cancers). Studies on smoking and SCC skin have had mixed results
(Aubry and MacGibbon, 1985; Karagas et al, 1992; Grodstein et al,
1995; Lear et al, 1998; De Hertog et al, 2001; Odenbro et al, 2005).
Current smokers were also at 3.9 (95% CI, 2.1–7.3) times the risk
of SCC of the skin of never smokers, which is not dissimilar to
estimates in other case–control studies where risks ranged from
2.3 to 3.3 (Aubry and MacGibbon, 1985; De Hertog et al, 2001).
However, we did not adjust for sun exposure, a primary risk factor
for SCC skin, and which is sometimes greater among smokers (De
Hertog et al, 2001).
Cardiovascular disease showed a two-fold increased risk among
smokers, which was approximately two-fold higher than non-
smokers; higher than that reported in a national study of tobacco-
related deaths (Sitas et al, 2004) and in other developing countries
such as China (Liu et al, 1998). Our risks are similar to those
observed in Western countries (Doll et al, 2004), although other
risk factors for cardiovascular disease, such as diet, were not
controlled for; a more comprehensive study incorporating these
factors is needed.
The smoking-related risks estimated in this study are likely to be
real in the black population of South Africa, as the prevalence of
current smokers among controls (18%) is comparable to that
reported by the South African Demographic and Health Survey
(SADHS) in 1998 (20.4%) (Steyn et al, 2002) and in the All Media
and Products Survey of the South African Advertising Research
Foundation in 2000 (22.7%) (van Walbeek, 2002a). Likewise, the
prevalence of former smokers (13%) in controls is similar to that
in the SADHS study (6.2% males and 10.3% females) (Steyn et al,
2002). However, because we used hospital-based controls, our risk
estimates may slightly underestimate the real risks.
The smoking-related risks reported here also indicate the
significant burden of disease from smoking in black South Africa,
even though tobacco consumption is very low compared to
developed countries. Of all 1998 adult deaths (aged 425), 8% were
attributed to smoking in an analysis of information on the death
notification form (Sitas et al, 2004). Smoking prevalence may
increase with the growth of the black middle class but is unlikely to
reach the levels seen in developed countries in the past, due to peer
attitudes and ever more stringent antitobacco legislation (Lopez
et al, 1994). Case–control studies and analysis of the smoking
questions on the national death notification form will allow the
burden of tobacco-related disease to be monitored.
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